Logo-jrip

Indexing Information

Scupos

Member of

Follower of





 

Epidemiology and Prevention

1. Boon and bane of remission induction with rituximab in ANCA-associated vasculitis: lessons learned from the RAVE-ITN follow-up study
Andreas Kronbichler*
J Renal Inj Prev. 2014;3(1): 9-10. doi: 10.12861/jrip.2014.05
PMCID: PMC4206041     PMID: 25340156    
Article
PDF
XML
Cited By:
0
News and Views

2. Thrombotic thrombocytopenic purpura treated with rituximab in systemic lupus erythematosus
Mansoor Karimifar*
J Renal Inj Prev. 2012;1(2): 53-54. doi: 10.12861/jrip.2012.19
PMCID: PMC4205987     PMID: 25340108    
Article
PDF
XML
Cited By:
2
Case Report

3. Non-ischemic cardiomyopathy after rituximab treatment for membranous nephropathy
Wisit Cheungpasitporn, Stephen L. Kopecky, Ulrich Specks, Kharmen Bharucha, Fernando C. Fervenza
J Renal Inj Prev. 2017;6(1): 18-25. doi: 10.15171/jrip.2017.04
PMCID: PMC5414514     PMID: 28487867     Scopus ID: 85040672073    
Article
PDF
XML
Cited By:
35
12
30
Review

4. Efficacy and Safety of rituximab in children with difficult-to-treat nephrotic syndrome; a systematic review
Anoush Azarfar, Yalda Ravanshad*, Hassan Mehrad-Majd, Shapour Badie Aval, Sanaz Nastarani, Maryam Emadzadeh, Mahmood Reza Khazaei, Mojtaba Fazel, Behnam Azimi
J Renal Inj Prev. 2018;7(4): 307-313. doi: 10.15171/jrip.2018.67
Scopus ID: 85054365592    
Article
PDF
XML
Cited By:
0
0
Original

5. Effect of rituximab on reducing the panel-reactive antibody in dialysis patients of transplant candidate
Asieh Aref ORCID, Samaneh Tirom* ORCID, Heshmatollah Shahbazian ORCID, Ali Ghorbani ORCID
J Renal Inj Prev. 2023;12(1): e31928. doi: 10.34172/jrip.2022.31928
Scopus ID: 85148582214    
Article
PDF
XML
Cited By:
0
0